Fatal Flaw: The Dangerous Spread of Coldrif Syrup

The Maharashtra FDA has called for an immediate halt to the sale or use of a batch of Coldrif syrup after child deaths in Madhya Pradesh and Rajasthan. The syrup, linked to renal failure, contains diethylene glycol, a poisonous substance. Authorities are tracing the distribution to prevent further risks.

The Maharashtra Food and Drug Administration issued an urgent appeal to cease the sale and use of a specific Coldrif syrup batch after child fatalities in Madhya Pradesh and Rajasthan. These tragic incidents have reportedly been linked to the medicine's consumption.

In an earlier report on October 2, Tamil Nadu drug control authorities identified the Coldrif syrup sample, batch SR-13, as adulterated. Manufactured by Sresan Pharmaceuticals, the syrup contained 48.6% diethylene glycol, a toxic substance posing a significant health risk.

Authorities are diligently collaborating with distributors across Maharashtra, aiming to recall affected stocks. Meanwhile, public warnings urge vigilance, advising any possession of the suspect batch to be reported to local drug authorities immediately.

(With inputs from agencies.)